Our approach

Discovering and developing new medicines and vaccines is tough. It requires huge investment, takes a long time and there’s a high rate of failure – especially when, in our quest for a breakthrough, we attempt things never tried before.

Our scientists work in smaller units focused on specific areas of research, seeking out the biological targets involved in disease and creating new molecules and antigens that could ultimately become a new medicine or vaccine.

Beyond working within GSK, we know that we won’t discover everything inside our own labs and that we need to adopt ‘Collaborative approach’ to partner with other companies, academic institutions and research charities to work together to explore new drugs and accelerate drug development.